Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Starting doses are conservative by design, and moving up requires clinical judgment, not just patient preference
The clinical results are unprecedented, with patients achieving 15 to 21% total body weight reduction in landmark trials
Tirzepatide has shown greater efficacy than semaglutide due to its dual action on glucagon-like peptide-1 and glucose-dependent insulinotropic peptide receptors
Hobart, especially for those patients without a known history of mental health concerns. However, she notes that there is still limited research available, and patients should do as much research as possible before starting a GLP-1
If your primary goal is significant weight loss, Wegovy could be the ideal choice
